Table 6: Comparison of Patient Survival Rates at Miami University Hospital.
Patient survival rates | 6 months | 1 year |
---|---|---|
Period I (6/94-12/97, cyclophosphamide, OK3, MMF) n=44 | 53% | 48% |
Period II (6/98-01/00, daclizumab) n=53 | 79% | 66% |
Period III (01/00-08/01, Campath-1H in adults) n=23 | 89% | ongoing |